Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lupus Science & Medicine|July 25, 2023
Improving resource utilisation in SLE drug development through innovative trial designSandra Garces, Elaine Karis, Joan T Merrill, et al.
The Journal of Investigative Dermatology|May 12, 2018
Ixekizumab Pharmacokinetics, Anti-Drug Antibodies, and Efficacy through 60 Weeks of Treatment of Moderate to Severe Plaque PsoriasisKristian Reich, Kimberley Jackson, Susan Ball, et al.
Cephalalgia : an International Journal of Headache|April 29, 2020
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraineJames M Martinez, Nada Hindiyeh, Greg Anglin, et al.
The AAPS Journal|March 15, 2025
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop ReportSophie Shubow, Michele Gunsior, Amy Rosenberg, et al.
Nature Reviews. Rheumatology|July 11, 2023
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforceKathryn Connelly, Laura E Eades, Rachel Koelmeyer, et al.
RMD Open|October 6, 2025
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspectiveElena W Y Hsieh, James B Chung, Afsah Amin, et al.
Lupus Science & Medicine|May 6, 2025
Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi studyKathryn Connelly, Rachel Koelmeyer, Darshini Ayton, et al.
Pageof 1